
Blank check company targeting businesses with growth potential and defensible market positions (pending: Vesicor Therapeutics).
Industry: SPAC
Latest Trade: $10.51 -0.69 (-6.2%)
First Day Return: +1.5%
Return from IPO: +12.0%
Industry: SPAC
| IPO Data | |
|---|---|
| IPO File Date | 02/05/2024 |
| Offer Price | $10.00 |
| Price Range $10.00 - $10.00 | |
| Offer Shares (mm) | 6.9 |
| Deal Size ($mm) | $69 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 03/20/2024 |
| Offer Price | $10.00 |
| Price Range $10.00 - $10.00 | |
| Offer Shares (mm) | 6.9 |
| Deal Size ($mm) | $69 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| Underwriters |
|---|
| D. Boral Capital |
| Company Data | |
|---|---|
| Headquarters | Danville, CA, United States |
| Founded | 2023 |
| Employees at IPO | 1 |
| Website bhspac.com | |